Passie, Torsten; Emrich, Hinderk M.; Karst, Matthias; Brandt, Simon D.; Halpern, John H. (2012). “Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence”. Drug Testing and Analysis4 (7-8): 649-659. doi:10.1002/dta.1377. PMID22736575.
Greer, George R.; Grob, Charles S.; Halberstadt, Adam L.; et al. (2014). “PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program”. Journal of Psychoactive Drugs46 (1): 73-77. doi:10.1080/02791072.2013.873843. PMID24830188.
Fraser, GA (2009). “The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)”. CNS Neurosci Ther15 (1): 84-88. doi:10.1111/j.1755-5949.2008.00071.x. PMID19228182.
Passie, Torsten; Emrich, Hinderk M.; Karst, Matthias; Brandt, Simon D.; Halpern, John H. (2012). “Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence”. Drug Testing and Analysis4 (7-8): 649-659. doi:10.1002/dta.1377. PMID22736575.
Greer, George R.; Grob, Charles S.; Halberstadt, Adam L.; et al. (2014). “PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program”. Journal of Psychoactive Drugs46 (1): 73-77. doi:10.1080/02791072.2013.873843. PMID24830188.
Fraser, GA (2009). “The Use of a Synthetic Cannabinoid in the Management of Treatment-Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)”. CNS Neurosci Ther15 (1): 84-88. doi:10.1111/j.1755-5949.2008.00071.x. PMID19228182.